Retrospective Study Evaluating ABRYSVO® Vaccine Effectiveness Against Severe Lower Respiratory Tract Disease in Older Adults First published 24/04/2025 Last updated 24/04/2025 EU PAS number:EUPAS1000000460 Study Ongoing